Welcure Drugs & Pharmaceuticals Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported revenue was INR 0.939 million compared to INR 2.37 million a year ago. Net loss was INR 1.75 million compared to net income of INR 1.02 million a year ago.

Basic loss per share from continuing operations was INR 0.129 compared to basic earnings per share from continuing operations of INR 0.075 a year ago. Diluted loss per share from continuing operations was INR 0.129 compared to diluted earnings per share from continuing operations of INR 0.075 a year ago.